Find Research Outputs

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Ayalew Tefferi
2016

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Patnaik, M. M. & Tefferi, A., Feb 5 2016, In : Blood Cancer Journal. 6, e393.

Research output: Contribution to journalArticle

45 Scopus citations
2015

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis

Pardanani, A., Tefferi, A., Jamieson, C., Gabrail, N., Lebedinsky, C., Gao, G., Liu, F., Xu, C., Cao, H. & Talpaz, M., Aug 14 2015, In : Blood cancer journal. 5, 8, e335.

Research output: Contribution to journalArticle

28 Scopus citations

Myeloproliferative Neoplasms: A Contemporary Review

Tefferi, A. & Pardanani, A. D., Apr 1 2015, In : JAMA oncology. 1, 1, p. 97-105 9 p.

Research output: Contribution to journalReview article

121 Scopus citations
2018

Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management

Elliott, M. A. & Tefferi, A., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. 578-587 10 p.

Research output: Contribution to journalArticle

8 Scopus citations
2013

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

Tefferi, A., Cervantes, F., Mesa, R., Passamonti, F., Verstovsek, S., Vannucchi, A. M., Gotlib, J., Dupriez, B., Pardanani, A., Harrison, C., Hoffman, R., Gisslinger, H., Kröger, N., Thiele, J., Barbui, T. & Barosi, G., Aug 22 2013, In : Blood. 122, 8, p. 1395-1398 4 p.

Research output: Contribution to journalArticle

160 Scopus citations
2011

How I treat myelofibrosis

Tefferi, A., Mar 31 2011, In : Blood. 117, 13, p. 3494-3504 11 p.

Research output: Contribution to journalReview article

96 Scopus citations
2015

New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera

Tefferi, A. & Barbui, T., Aug 1 2015, In : American journal of hematology. 90, 8, p. 683-685 3 p.

Research output: Contribution to journalComment/debate

17 Scopus citations
2011

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis

Pardanani, A., Gotlib, J. R., Jamieson, C., Cortes, J. E., Talpaz, M., Stone, R. M., Silverman, M. H., Gilliland, D. G., Shorr, J. & Tefferi, A., Mar 1 2011, In : Journal of Clinical Oncology. 29, 7, p. 789-796 8 p.

Research output: Contribution to journalArticle

299 Scopus citations
2014

Definition and management of ruxolitinib treatment failure in myelofibrosis

Pardanani, A. & Tefferi, A., Jan 1 2014, In : Blood cancer journal. 4, 12, p. e268

Research output: Contribution to journalArticle

24 Scopus citations
2011

Mutations galore in myeloproliferative neoplasms: Would the real Spartacus please stand up

Tefferi, A., Jul 1 2011, In : Leukemia. 25, 7, p. 1059-1063 5 p.

Research output: Contribution to journalReview article

19 Scopus citations
2012

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

Tefferi, A., Mar 1 2012, In : New England Journal of Medicine. 366, 9, p. 844-846 3 p.

Research output: Contribution to journalEditorial

44 Scopus citations
2017

Diagnostic impact of the 2016 revised who criteria for polycythemia vera

Barbui, T., Thiele, J., Gisslinger, H., Carobbio, A., Vannucchi, A. M. & Tefferi, A., May 1 2017, In : American journal of hematology. 92, 5, p. 417-419 3 p.

Research output: Contribution to journalComment/debate

10 Scopus citations
2011

Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis

Tefferi, A. & Pardanani, A., Dec 2011, In : Mayo Clinic proceedings. 86, 12, p. 1188-1191 4 p.

Research output: Contribution to journalArticle

125 Scopus citations
2013

Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia

Barbui, T., Thiele, J., Vannucchi, A. M. & Tefferi, A., Oct 1 2013, In : Leukemia. 27, 10, p. 1953-1958 6 p.

Research output: Contribution to journalReview article

53 Scopus citations
2015
2 Scopus citations
2014

Masked polycythemia vera diagnosed according to WHO and BCSH classification

Barbui, T., Thiele, J., Carobbio, A., Gisslinger, H., Finazzi, G., Rumi, E., Luigia Randi, M., Vannucchi, A. M., Gisslinger, B., Müllauer, L., Ruggeri, M., Rambaldi, A. & Tefferi, A., Feb 20 2014, In : American journal of hematology. 89, 2, p. 199-202 4 p.

Research output: Contribution to journalArticle

46 Scopus citations
2017

Revisiting the need for bone marrow examination in chronic myeloid leukemia

Tefferi, A., Hanson, C. A. & Ketterling, R. P., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

1 Scopus citations
2015

Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice

Tefferi, A. & Barbui, T., Sep 1 2015, In : Mayo Clinic proceedings. 90, 9, p. 1283-1293 11 p.

Research output: Contribution to journalArticle

23 Scopus citations
2011

Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype

Patnaik, M. M., Hanson, C. A., Hodnefield, J. M., Knudson, R., Van Dyke, D. L. & Tefferi, A., Feb 2011, In : Leukemia. 25, 2, p. 266-270 5 p.

Research output: Contribution to journalArticle

77 Scopus citations
2015

Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis

Barbui, T., Vannucchi, A. M., Carobbio, A., Thiele, J., Rumi, E., Gisslinger, H., Rodeghiero, F., Randi, M. L., Rambaldi, A., Pieri, L., Pardanani, A., Passamonti, F., Finazzi, G. & Tefferi, A., May 1 2015, In : American journal of hematology. 90, 5, p. 434-437 4 p.

Research output: Contribution to journalArticle

8 Scopus citations
2011

Polycythemias, Essential Thrombocythemia, and Primary Myelofibrosis

Tefferi, A., Jul 1 2011, Goldman's Cecil Medicine: Twenty Fourth Edition. Elsevier Inc., Vol. 1. p. 1090-1098 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2018

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation

Bikhchandani, M., Johnson, R., Tuan, B. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Acta Haematologica. p. 67-70 4 p.

Research output: Contribution to journalArticle

2019

Comments on pre-fibrotic myelofibrosis and how should it be managed

Barbui, T., Thiele, J., Gisslinger, H., Orazi, A., Vannucchi, A. M., Gianelli, U., Beham-Schmid, C. & Tefferi, A., Jul 2019, In : British journal of haematology. 186, 2, p. 358-360 3 p.

Research output: Contribution to journalLetter

Open Access
2 Scopus citations
2012

The editorialist replies

Tefferi, A., May 24 2012, In : New England Journal of Medicine. 366, 21, p. 2034-2035 2 p.

Research output: Contribution to journalLetter

2011

Chronic myeloid leukemia 2011: Successes, challenges, and strategies-Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

Mughal, T. I., Radich, J. P., van Etten, R. A., Quintás-Cardama, A., Skorski, T., Ravandi, F., Deangelo, D. J., Gambacorti-Passerini, C., Martinelli, G. & Tefferi, A., Sep 1 2011, In : American journal of hematology. 86, 9, p. 811-819 9 p.

Research output: Contribution to journalArticle

4 Scopus citations
2018

Blast-phase chronic myelomonocytic leukemia: more than just semantics

Patnaik, M. M., Tefferi, A. & Garcia-Manero, G., Sep 1 2018, In : Leukemia. 32, 9, p. 2093-2094 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2014

Primary Myelofibrosis

Tefferi, A., Jun 20 2014, Cancer Consult: Expertise for Clinical Practice. Wiley Blackwell, p. 162-166 5 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2017
31 Scopus citations
2016

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis: A practical review

Farhadfar, N., Cerquozzi, S., Patnaik, M. M. & Tefferi, A., Jul 1 2016, In : Journal of Oncology Practice. 12, 7, p. 611-621 11 p.

Research output: Contribution to journalReview article

12 Scopus citations
2018

Polycythemia vera and essential thrombocythemia: Algorithmic approach

Vannucchi, A. M., Guglielmelli, P. & Tefferi, A., Mar 1 2018, In : Current Opinion in Hematology. 25, 2, p. 112-119 8 p.

Research output: Contribution to journalReview article

3 Scopus citations
2012

Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium

Abdel-Wahab, O., Pardanani, A., Bernard, O. A., Finazzi, G., Crispino, J. D., Gisslinger, H., Kralovics, R., Odenike, O., Bhalla, K., Gupta, V., Barosi, G., Gotlib, J., Guglielmelli, P., Kiladjian, J. J., Noel, P., Cazzola, M., Vannucchi, A. M., Hoffman, R., Barbui, T., Thiele, J. & 3 others, Van Etten, R. A., Mughal, T. & Tefferi, A., May 1 2012, In : American journal of hematology. 87, 5, p. 562-568 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients

Barosi, G., Tefferi, A. & Barbui, T., May 2012, In : Leukemia. 26, 5, p. 1148-1149 2 p.

Research output: Contribution to journalLetter

10 Scopus citations
2014

Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification

Barbui, T., Thiele, J., Kvasnicka, H. M., Carobbio, A., Vannucchi, A. M. & Tefferi, A., Oct 1 2014, In : Leukemia. 28, 10, p. 2092-2094 3 p.

Research output: Contribution to journalLetter

8 Scopus citations
2016

Myeloproliferative neoplasms: A decade of discoveries and treatment advances

Tefferi, A., Jan 1 2016, In : American Journal of Hematology. 91, 1, p. 50-58 9 p.

Research output: Contribution to journalArticle

66 Scopus citations
2011

BCR-ABL1-negative myeloproliferative neoplasms: A review of molecular biology, diagnosis, and treatment

Vakil, E. & Tefferi, A., Jun 2011, In : Clinical Lymphoma, Myeloma and Leukemia. 11, SUPPL.1, p. S37-S45

Research output: Contribution to journalArticle

20 Scopus citations

Autosomal monosomies among 24,262 consecutive cytogenetic studies: Prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities

Raza, S., Tahernazerhussain, F., Patnaik, M., Knudson, R., Van Dyke, D. & Tefferi, A., Apr 1 2011, In : American journal of hematology. 86, 4, p. 353-356 4 p.

Research output: Contribution to journalArticle

13 Scopus citations
2013

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management

Tefferi, A., Feb 1 2013, In : American journal of hematology. 88, 2, p. 141-150 10 p.

Research output: Contribution to journalArticle

78 Scopus citations
2014

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients

Barbui, T., Thiele, J., Carobbio, A., Guglielmelli, P., Rambaldi, A., Vannucchi, A. M. & Tefferi, A., May 2014, In : American journal of hematology. 89, 6, p. 588-590 3 p.

Research output: Contribution to journalArticle

50 Scopus citations
2018

Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia

Tefferi, A., Oct 1 2018, In : Hematological Oncology. 36, 4, p. 718-720 3 p.

Research output: Contribution to journalLetter

4 Scopus citations
2011

Xanthoma disseminatum: Effective therapy with 2-chlorodeoxyadenosine in a case series

Khezri, F., Gibson, L. E. & Tefferi, A., Apr 1 2011, In : Archives of Dermatology. 147, 4, p. 459-464 6 p.

Research output: Contribution to journalArticle

28 Scopus citations
2012

Overcoming "aspirin resistance" in MPN

Tefferi, A., Apr 12 2012, In : Blood. 119, 15, p. 3377-3378 2 p.

Research output: Contribution to journalComment/debate

7 Scopus citations
2011

The American Journal of Hematology, 2011 and beyond

Brugnara, C. & Tefferi, A., Jan 1 2011, In : American journal of hematology. 86, 1, p. 1 1 p.

Research output: Contribution to journalEditorial

2019
9 Scopus citations
2011
6 Scopus citations
2013

Nilotinib treatment-associated cerebrovascular disease and stroke

Coon, E. A., Zalewski, N. L., Hoffman, E. M., Tefferi, A. & Flemming, K. D., Jun 1 2013, In : American journal of hematology. 88, 6, p. 534-535 2 p.

Research output: Contribution to journalLetter

26 Scopus citations

Thrombocytosis and Essential Thrombocythemia

Tefferi, A., Aug 27 2013, Platelets. Elsevier Inc., p. 999-1017 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Personalized management of essential thrombocythemia - Application of recent evidence to clinical practice

Tefferi, A. & Barbui, T., Aug 1 2013, In : Leukemia. 27, 8, p. 1617-1620 4 p.

Research output: Contribution to journalReview article

41 Scopus citations
24 Scopus citations
2012

Why Does My Patient Have Thrombocytosis?

Sulai, N. H. & Tefferi, A., Apr 1 2012, In : Hematology/Oncology Clinics of North America. 26, 2, p. 285-301 17 p.

Research output: Contribution to journalReview article

15 Scopus citations
2014

Associate editor's note

Tefferi, A., Jan 2014, In : Mayo Clinic proceedings. 89, 1, 1 p.

Research output: Contribution to journalLetter